Vera Therapeutics, Inc.
VERA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,340 | $657 | $514 | $569 |
| - Cash | $93 | $46 | $115 | $80 |
| + Debt | $55 | $54 | $31 | $5 |
| Enterprise Value | $2,302 | $665 | $431 | $494 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$144 | -$92 | -$89 | -$32 |
| % Margin | – | – | – | – |
| Net Income | -$152 | -$96 | -$89 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.75 | -2.25 | -3.35 | -2.43 |
| % Growth | -22.2% | 32.8% | -37.9% | – |
| Operating Cash Flow | -$135 | -$92 | -$68 | -$24 |
| Capital Expenditures | -$1 | -$0 | -$0 | $0 |
| Free Cash Flow | -$136 | -$92 | -$68 | -$24 |